The updated antigenic composition of the Sputnik Light vaccine against COVID-19 has been approved by the Ministry of Health of the Russian Federation for clinical trials. The drug will be studied for safety and immunogenicity in trials with a sample of 100 volunteers. The testing phase will conclude by December 31, 2024.
Deputy Minister of Health of the Russian Federation, Tatyana Semenova, recently announced that the enhanced Sputnik Light vaccine will soon be accessible to the masses by autumn.
